RxDoctor Payments Data

Shari Villafane, APRN

Family · Cleveland, OHNPI 1023501392

Payments from drug & device makers

$66in general payments, 2019–2025

Across 3 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$30
  • Organogenesis Inc.$21
  • Solventum Corporation$15

What the payments were for

  • Food & beverage$66100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$66 in reported general payments places this provider in the 20th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$1,415,846
Medicare patients
93
Services billed
1,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amlodipine Besylate24$190
Pravastatin Sodium11$136
Tramadol Hcl18$89

Paid to pharmacies, not to this prescriber.

Other family in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →